Lilly wins chemotherapy patent appeal


The UK supreme court has ruled that Actavis (now part of Accord Healthcare in the UK and Ireland), which produced alternative forms of chemotherapy drug Alimta (pemetrexed), directly infringed patents held by Eli Lilly in the UK, France, Spain and Italy. The full article was published at Chemistry World.

IMAGE: Paul Sableman -- Flickr